Menu Search
Equities

Bio Essence Corp

BIOE:PKC

Bio Essence Corp

Actions
  • Price (USD)0.275
  • Today's Change-0.060 / -17.85%
  • Shares traded3.49k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 19:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bio Essence Corp's revenues fell -11.27% from 621.59k to 551.51k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 809.68k to a larger loss of 971.88k.
Gross margin25.05%
Net profit margin-172.74%
Operating margin-175.05%
Return on assets-57.09%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Bio Essence Corp fell by 6.15k. Cash Flow from Financing totalled 1.11m or 201.45% of revenues. In addition the company used 1.03m for operations while cash used for investing totalled 91.48k.
Cash flow per share-0.0268
Price/Cash flow per share--
Book value per share-0.0458
Tangible book value per share-0.0458
More ▼

Balance sheet in USDView more

Bio Essence Corp has a Debt to Total Capital ratio of 702.88%.
Current ratio0.2948
Quick ratio--
Total debt/total equity--
Total debt/total capital7.03
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.